Yuanxi Zhou
Director of Medicinal Chemistry
BUSINESS MANAGEMENT
Alectos Therapeutics
United States of America
Biography
Dr. Zhou completed her doctoral studies in the field of organic chemistry at the University of Alberta. She received postdoctoral training at Florida State University with Prof Holton where she contributed to the total synthesis of Taxol. Dr. Zhou brings over seventeen years of diverse experience in small molecule drug discovery having held positions at Neuromed and AnorMED, where she was involved in the discovery of the clinical CXCR4 antagonist AMD070 and led efforts to discover preclinical candidates for treatment of neuropathic pain, epilepsy, and HIV. Dr. Zhou joined Alectos Therapeutics in 2009 as the Director of Medicinal Chemistry, with responsibilities including oversight of the collaboration with Merck & Co., Inc. She is co-author on over 48 publications and patents. Dr. Zhou completed her doctoral studies in the field of organic chemistry at the University of Alberta. She received postdoctoral training at Florida State University with Prof Holton where she contributed to the total synthesis of Taxol. Dr. Zhou brings over seventeen years of diverse experience in small molecule drug discovery having held positions at Neuromed and AnorMED, where she was involved in the discovery of the clinical CXCR4 antagonist AMD070 and led efforts to discover preclinical candidates for treatment of neuropathic pain, epilepsy, and HIV. Dr. Zhou joined Alectos Therapeutics in 2009 as the Director of Medicinal Chemistry, with responsibilities including oversight of the collaboration with Merck & Co., Inc. She is co-author on over 48 publications and patents.
Research Interest
BUSINESS MANAGEMENT
